stella
beta
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine — Stella
Home
/
Chronic Migraine
/
View on ClinicalTrials.gov
Recruiting
Back to Chronic Migraine trials
Trial locations
(4 sites)
South Korea
Hallym University Dongtan Sacred Heart Hospital /ID# 273581, Hwaseong, Gyeonggido
Seoul National University Hospital /ID# 271892, Seoul, Seoul Teugbyeolsi
Kangbuk Samsung Hospital /ID# 271893, Seoul, Seoul Teugbyeolsi
Yonsei University Health System Severance Hospital /ID# 272639, Seoul, Seoul Teugbyeolsi